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Abstract
Introduction: Lesotho was among the first countries to adopt decentralization of care from hospitals to nurse-led health centres
(HCs) to scale up the provision of antiretroviral therapy (ART).We compared outcomes between patients who started ART at HCs
and hospitals in two rural catchment areas in Lesotho.
Methods: The two catchment areas comprise two hospitals and 12 HCs. Patients ]16 years starting ART at a hospital or HC
between 2008 and 2011 were included. Loss to follow-up (LTFU) was defined as not returning to the facility for ]180 days after
the last visit, no follow-up (no FUP) as not returning after starting ART, and retention in care as alive and on ART at the facility.
The data were analysed using logistic regression, competing risk regression and Kaplan-Meier methods. Multivariable analyses
were adjusted for sex, age, CD4 cell count, World Health Organization stage, catchment area and type of ART. All analyses were
stratified by gender.
Results: Of 3747 patients, 2042 (54.5%) started ART at HCs. Both women and men at hospitals had more advanced clinical
and immunological stages of disease than those at HCs. Over 5445 patient-years, 420 died and 475 were LTFU. Kaplan-Meier
estimates for three-year retention were 68.7 and 69.7% at HCs and hospitals, respectively, among women (p0.81) and 68.8%
at HCs versus 54.7% at hospitals among men (pB0.001). These findings persisted in adjusted analyses, with similar retention at
HCs and hospitals among women (odds ratio (OR): 0.89, 95% confidence interval (CI): 0.731.09) and higher retention at HCs
among men (OR: 1.53, 95% CI: 1.201.96). The latter result was mainly driven by a lower proportion of patients LTFU at HCs
(OR: 0.68, 95% CI: 0.510.93).
Conclusions: In rural Lesotho, overall retention in care did not differ significantly between nurse-led HCs and hospitals. However,
men seemed to benefit most from starting ART at HCs, as they were more likely to remain in care in these facilities compared to
hospitals.
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HIV.
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Introduction
Scarce human resources for health are a major obstacle to
the scale-up of antiretroviral therapy (ART) in rural Africa
[1,2]. In response, the World Health Organization (WHO)
recommends that, whenever possible, tasks should be shifted
to less specialized health workers [3], in line with the WHO’s
public health approach to ART in resource-limited settings
[4]. Nurses may partly or completely take over the provision
of ART to HIV-infected patients [5]. To compensate for the
additional workload, other tasks, such as HIV testing and
counselling or adherence and psychosocial counselling, may
be shifted to lay personnel. Such task shifting allows the
decentralization of ART provision to nurse-led primary
healthcare clinics.
Through task shifting and decentralization, several coun-
tries in sub-Saharan Africa, such as Zambia, Ethiopia and
Malawi, managed to scale up ART provision substantially
[68]. A systematic review concluded that task shifting offers
high-quality and cost-effective HIV care to more patients than
physician-centred models [9]. The results of two clinical trials
confirmed these findings by showing that nurse-monitored
ART was non-inferior in terms of virological suppression and
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retention in care [10] and that nurse-based initiation
and follow-up (FUP) of ART resulted in a similar mortality
rate as compared to physician-based care [11]. Cohort
studies in settings with decentralized HIV care have uniformly
reported favourable outcomes, including improved reten-
tion in care [1219]. However, most studies assessed short-
term clinical outcomes in pilot programmes focusing on a
single district, and the generalizability of these findings is
unclear. Data on the outcomes of full decentralization in
regard to start and FUP of ART at the health centre (HC)
level are still scarce. A recent Cochrane Review, including
two cluster-randomized trials and 14 cohort studies, found
moderate quality of evidence that partial decentraliza-
tion (ART started by physicians at hospitals and FUP
decentralized to nurse-led HCs) probably reduces attrition.
For full decentralization (start and FUP of ART at the HC
level), their analysis was inconclusive due to very low quality
of evidence [20].
Lesotho has the third-highest HIV prevalence in the world
and is particularly hit by the shortage of human resources
for health [2123]. In 2007, it was one of the first countries
to decentralize the initiation and FUP of ART to nurse-led HCs
on a national scale. This was facilitated by the development
of national guidelines tailored to nurses who work in primary
healthcare settings [24]. In a recent study of ART outcomes in
rural southern Africa, we showed that among patients
treated in Lesotho, only 55% were alive and in care three
years after enrolment [25]. The aim of this study is to assess
the effectiveness of decentralized nurse-based ART pro-
grammes by comparing three-year outcomes between pa-
tients who initiated ART at HCs and those who started
treatment at hospitals in two geographically and demogra-
phically different catchment areas in rural Lesotho. By
stratifying all analyses by gender, we intended to assess
differences in outcomes between women and men starting
ART in HCs and hospitals.
Methods
Study setting
The study includes data from the catchment areas of two
hospitals in rural Lesotho. Seboche, located in Botha-Bothe
district in northern Lesotho, has an estimated population of
55,000. It is served by one hospital and five HCs. Paray
belongs to the mountainous district of Thaba-Tseka in central
Lesotho, has about 77,000 inhabitants and is served by one
hospital and seven HCs. According to the 2009 Demographic
and Health Survey, Thaba-Tseka had an adult HIV prevalence
of 20.1% and Botha-Bothe of 15.9%. Both areas are rural, and
the majority of people are subsidence farmers. Compared
to Seboche, Paray is more remote, with longer distances to
the healthcare facilities, and its population is poorer, has
a lower literacy rate and is confronted with higher levels
of food insecurity and malnutrition. It was estimated that
the proportion belonging to the lowest wealth quintile was
53.7% in Paray and 20.4% in Seboche, and the rate of
stunting among children was 23.1 and 9.5%, respectively
[26].
The two hospitals started providing ART in 2005. In 2007,
in response to severe staff shortages, Lesotho published new
national guidelines and started to implement a nurse-based
model to decentralize and scale-up ART provision [12,27].
In the two study areas, this process was completed by mid-
2008. However, laboratory examinations were not decentra-
lized to the HC level. Blood samples are transported weekly
from the HCs by motorbike to the referral hospitals.
Nurses receive the laboratory results 3 to 7 days after blood
was drawn. Both hospitals supervise the HCs within their
catchment areas and serve as referral facilities. The hospitals
are staffed with four physicians per site and provide
laboratory services for basic analyses, including CD4 cell
counts. Viral load testing is not available on site and not done
routinely. The HCs are usually staffed with one registered
nurse acting as a nurse-clinician and one nurse-assistant as
well as 13 lay or community counsellors. The lay counsellors
perform HIV counselling and testing and adherence monitor-
ing and counselling, and they trace patients who are lost
to follow-up (LTFU). The nurse-clinician and, in some cases,
the nurse-assistant initiate ART and manage the clinical
monitoring of patients. Table 1 summarizes the resources
available for HIV care at the HCs and hospitals. There are no
data on the actual travel times of patients to the facility.
However, we estimate that average travel times are 2 and
1.5 hours to the Paray and Seboche hospitals, respectively.
The estimated average travel time to the HCs is shorter: 1.5
and 1 hour, respectively.
Both areas benefit from health projects supported by
SolidarMed, a Swiss non-governmental organization (NGO).
The SolidarMed ART project (SMART) has supported the
implementation of the national ART programme since 2005.
A more detailed description of the SMART programme can be
found elsewhere [25]. The SMART programme in Lesotho is
part of the International Epidemiologic Databases to Evaluate
AIDS in Southern Africa (IeDEA-SA), a collaboration of ART
programmes from seven countries in the region [28].
Data collection
Individual patient data are obtained from the national ART
patient sheets that are completed for all patients initiated
on ART in Lesotho. Since 2005, data-managers have visited
the facilities monthly to enter the paper-based data into an
electronic database. Each patient starting ART in Lesotho
receives a unique national identifier number, which is kept in
case of transfer. It is entered into the database and allows
identification of the facility at which patients initiated ART.
The registered data contain information on basic demo-
graphic indicators (age and sex) as well as clinical (WHO stage,
opportunistic infections, drug-related side effects, concurrent
tuberculosis and pregnancy) and laboratory parameters (CD4
cell count, haemoglobin and creatinine). A data coordinator
performs regular quality checks of the database, and addi-
tional checks are performed by SolidarMed staff and IeDEA-SA
data managers.
Inclusion criteria and outcomes
All patients aged 16 years or older who started ART with at
least three drugs (two nucleoside reverse transcriptase
inhibitors (NRTIs) and one non-nucleoside reverse transcrip-
tase inhibitor (NNRTI)) within the two catchment areas
between January 2008 and April 2011 were included.
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We assessed the following outcomes: retention in care, no
FUP, LTFU and mortality. Retention in care was defined as
alive on ART and in active FUP at database closure. No FUP
was defined as no visits after the initiation of ART. LTFU was
defined as not returning to the healthcare facility for six
months or longer after at least one FUP visit, and not being
reported dead or transferred out. Patients with no FUP after
ART initiation were excluded from analyses of LTFU and
mortality. Transfers of patients had to be confirmed by a
national transfer letter. The analysis closure date was October
31, 2011. Patients who started ART within six months prior to
the closure date could not be classified regarding LTFU and
were excluded from all analyses. FUP was censored three
years after initiation of ART.
Statistical analyses
Comparisons were made between hospitals and HCs.
All analyses were stratified by gender. Baseline characteristics
were compared using Mann-Whitney and Pearson’s chi-
square tests for continuous and categorical variables, respec-
tively. Retention in care was examined in Kaplan-Meier
curves and log rank tests. We used a multivariable logistic
regression model to identify individual and programmatic
characteristics associated with no FUP, and we used compet-
ing risk regression to assess risk factors for LTFU or death
[29]. The competing risk model accounts for the fact that the
risk of death and LTFU may not be mutually exclusive [30].
Three-year retention in care at HCs versus hospitals was
assessed using multivariable logistic regression. All multi-
variable models included the following individual and pro-
grammatic characteristics: age (1629, 3039 or ]40 years),
CD4 cell count (049, 5099, 100199 or ]200 cells/mL),
clinical WHO stage (I/II or III/IV), type of NNRTI (nevirapine
(NVP) or efavirenz (EFV)) and catchment area (Seboche or
Paray).
Ethical considerations
This study was approved by the Ethical Committee of
the Ministry of Health and Social Welfare of Lesotho. The
collaboration with IeDEA-SA was approved by the Institu-
tional Review Board of Baylor College of Medicine Children’s
Foundation Lesotho.
Results
Patient characteristics
Between January 2008 and April 2011, 3969 adult patients
were enrolled in the SolidarMed ART programme in Lesotho.
Of these, 222 (5.6%) were excluded from the analyses as they
had initiated treatment elsewhere. Of the remaining 3747
patients, 2042 (54.5%) started ART at one of the 12 HCs, and
the others at one of the two hospitals (Figure 1). Flow charts
stratified by gender are shown in the Supplementary file.
Patients in HCs had less advanced clinical disease and higher
CD4 cell counts and haemoglobin levels than those in
hospitals. These differences were consistent across gender
(Table 2) and catchment area (Web-Table 1). Patients
in hospitals were more likely to start a tenofovir-containing
ART regimen than those at HCs, and, in the Paray region,
they were more likely to be prescribed EFV than patients in
HCs. Finally, sex and age distribution were similar in HCs and
hospitals.
Retention in care
Over 5445 person-years of FUP, overall retention in care was
66.6% (95% CI: 64.568.6) at three years. Disaggregated by
facility type, three-year retention in care was 68.8% (95% CI:
65.771.6) in HCs and 64.1% (95% CI: 61.166.9) in hospitals.
Kaplan-Meier estimates for three-year retention among
female patients were 69.4 and 68.7% at hospitals and HCs,
respectively (p0.81; Figure 2A). Among male patients,
three-year retention was higher at HCs compared to hospitals:
68.8% versus 54.7% (pB0.001; Figure 2B). The difference
Table 1. Resources available for ART services at the two hospitals and the 12 health centres involved in the study
Seboche Paray
Hospital
(n1)
Health centres
(n5)
Hospital
(n1)
Health centres
(n7)
Number of physicians 4 0 4 0
Number of nurse-clinicians per facility providing ART 3 1 2 1
Number of nurse-assistants per facility involved in ART 2 1 3 1
Number of lay counsellors per facility 5 2 7 2
Number of new adult patients enrolled in ART per facility from 1 January
2008 to 30 April 2011
873 159 832 178
Nurse-clinician/patient ratio 1/291 1/159 1/419 1/178
CD4 testing on site Yes No Yes No
Haemoglobin testing on site Yes 2 out of 5 Yes 2 out of 7
Biochemistry on site Yes No Yes No
Viral load testing on site No No No No
TB services available Yes Yes Yes Yes
Sputum microscopy on site Yes No Yes No
X-ray on site Yes No Yes No
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in the proportion of male patients retained in care between
HCs and hospitals was consistent across catchment areas
(Paray: 71.1% versus 57.3% at three years, p0.002; and
Seboche: 65.9% versus 52.3%, p0.001).
In adjusted logistic regression, men treated at HCs were
significantly more likely to be retained at three years
compared to those treated at hospitals (odds ratio (OR):
1.53, 95% confidence interval (CI): 1.201.96). There was
no significant difference in retention in care at three years
between women who started ART at HCs and those who
initiated at hospitals (OR: 0.89, 95% CI: 0.731.09) (Table 3).
These findings were consistent across catchment areas
(retention in men (HCs versus hospitals): Paray: 1.51
(1.082.11), and Seboche: 1.45 (0.992.13); and reten-
tion in women: Paray: 0.83 (0.631.09), and Seboche: 0.98
(0.721.33)).
Determinants of retention in care, by gender
Thirty-two women (2.9%) who started ART in hospitals and
22 (1.7%) who started in HCs had no FUP visit. Among men,
18 (2.9%) in the hospitals and 13 (1.8%) in the HCs had no
FUP. In adjusted logistic regression, patients enrolled at HCs
were less likely to have no FUP visit compared to those
at hospitals (OR 0.62, 95% CI: 0.390.98). After stratification
by gender, the point estimates remained similar in men and
women (Table 3).
During the study period, 420 patients (11.5%) with at
least one FUP visit died and 475 (12.9%) were LTFU. Overall,
the proportion of patients who died or were LTFU was
slightly lower in HCs compared to hospitals (10.1% vs. 13.5%
of patients died, and 12.7% vs. 13.9% were LTFU). In adjusted
analyses, male patients were less likely to be LTFU in HCs
compared to hospitals (OR: 0.68, 95% CI: 0.510.93), but
this was not true for female patients (OR: 1.21, 95% CI:
0.951.51). For both sexes, there was no significant differ-
ence in mortality between HCs and hospitals (Table 3).
Discussion
We compared clinical outcomes between patients who
initiated ART at HCs and hospitals in two geographically
distinct rural catchment areas in Lesotho. Across gender and
catchment areas, HCs enrolled patients with less advanced
clinical disease and better immunological status. In line with
recent publications on task shifting of ART delivery, overall
retention in care was at least as high at HCs compared to
hospitals [15,1719]. However, in stratified analyses,
men enrolled at HCs were more likely to be retained in
care compared to those at hospitals, whereas among women,
retention was similar in all settings. These results were
mainly driven by the high proportion of male patients LTFU
after starting ART at hospitals.
Several cohort studies have demonstrated favourable
short-term outcomes in patients who were treated in
decentralized ART programmes in sub-Saharan Africa [12
14,1618]. However, reports on direct comparisons of three-
year retention in care between patients treated in hospitals
and those in fully decentralized settings, where both ART
initiation and FUP are shifted to nurses, are scarce. In a
previous study from Lesotho, Cohen et al. showed that 77%
of adults were alive and on ART two years after enrolment,
but they did not specifically compare clinical outcomes
between hospitals and HCs [12]. In a study of 16 HCs in
Malawi, mortality and LTFU rates were lower in nurse-led HCs
compared to their affiliated hospital [31]. Of note, most of
3,969 adult patients enrolled on ART from
1st Jan 2008 to 30st April 2011
222 started outside study-area
1,705 initiated ART at hospital level
21 no follow-up
113 LTFU
102 Died
811 patients analyzed
111 LTFU
116 Died
844 patients analyzed
194 LTFU
80 Died
1,219 patients analyzed
57 LTFU
122 Died
788 patients analyzed
29 no follow-up 28 no follow-up 7 no follow-up
832 at Paray Hospital 873 at Seboche Hospital 1,247 at Paray HC 795 at Seboche HC
2,042 initiated ART at health
center level
Figure 1. Flow chart of patients starting antiretroviral therapy (ART) in health centres (HCs) and hospitals (flow charts stratified by gender
are displayed in the Supplementary file). LTFU: Lost to follow-up
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Table 2. Baseline characteristics of patients starting ART in hospitals and health centres (HCs), stratified by gender (see Web-Table 1 for stratification by catchment area)
Female patients (n2395) Male patients (n1352)
Hospital HC p Hospital HC p Total
Number of patients 1086 1309 619 733 3747
Median age in years (IQR) 35 (3045) 39 (3349) 0.021 37 (3048) 42 (3550) 0.017 38 (3148)
Median CD4 cell count/ml (IQR) 183 (86281) 223 (142296) B0.001 138 (60233) 196 (102276) B0.001 194 (102281)
CD4 categories (cells/ml) (%) B0.001 B0.001
049 137 (12.6) 77 (5.9) 117 (18.9) 87 (11.9) 418 (11.2)
5099 163 (15.0) 100 (7.6) 112 (18.1) 83 (11.3) 458 (12.2)
100199 267 (42.6) 368 (28.1) 169 (27.3) 191 (26.1) 995 (26.6)
]200 486 (44.8) 730 (55.8) 197 (31.8) 344 (46.9) 1757 (46.9)
Missing 33 (3.0) 34 (2.6) 24 (3.9) 28 (3.8) 119 (3.2)
Median haemoglobin (g/dl) 11.3 (10.012.6) 12 (11.013.0) B0.001 12.4 (10.814.0) 12.9 (11.514.7) 0.004 11.9 (10.613.2)
Missing haemoglobin (%) 422 (38.9) 889 (67.9) B0.001 272 (43.9) 513 (69.9) B0.001 2096 (55.9)
WHO stage (%) B0.001 B0.001
I/II 607 (55.9) 959 (73.4) 242 (39.1) 426 (58.2) 2234 (59.7)
III/IV 479 (44.1) 348 (26.6) 377 (60.9) 306 (41.8) 1510 (40.3)
NNRTI 0.003 0.044
NVP based (%) 421 (38.8) 589 (45.0) 126 (20.4) 184 (25.1) 1320 (35.2)
EFV based (%) 658 (60.6) 416 (54.7) 488 (78.8) 547 (74.6) 2409 (64.6)
NRTI
3TC/D4T (%) 175 (16.1) 312 (23.8) B0.001 82 (13.3) 181 (24.6) B0.001 749 (19.9)
3TC/AZT (%) 339 (31.2) 526 (40.2) B0.001 156 (25.2) 179 (24.4) 0.740 1198 (31.9)
3TC/TDF (%) 567 (52.2) 469 (35.8) B0.001 381 (61.6) 371 (50.6) B0.001 1782 (47.6)
IQR: interquartile range; NNRTI: non-nucleoside reverse-transcriptase inhibitor; NtRTI: nucleoside analogue reverse-transcriptase inhibitor; 3TC: lamivudine; D4T: stavudine; AZT: zidovudine; TDF: tenofovir.
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the HCs in this programme only managed the FUP of patients
on ART and did not initiate treatment (partial decentraliza-
tion). Recently published evidence from three clinical trials
confirmed these encouraging observational cohort data.
In the Comprehensive International Program of Research
on AIDS trial in South Africa, nurse-monitored ART was non-
inferior to doctor-led monitoring in terms of virological and
clinical outcomes [10]. In a cluster-randomized trial, Fairall
et al. showed that task shifting of ART initiation and
management to nurses was safe, with equivalent mortality
and rates of virological suppression compared to the doctor-
led model [11]. Finally, in Uganda, Jaffar and colleagues
showed that for monitoring of patients who are on ART,
an even higher degree of task shifting was non-inferior to
more conventional approaches. They showed that patients
monitored at home by trained and closely supervised
lay cadres had similar outcomes in terms of mortality and
viral suppression compared to patients followed at the
facility [32]. However, conditions in a trial often differ from
routine settings. Thus, the results of these trials might not be
transferrable to routine HIV care in high-burden rural settings
with scarce health resources, as is the case in Lesotho.
Our study provides evidence that even in rural, resource-
constrained settings with limited infrastructure and less
intensive support to nurses than in clinical trials, task shifting
and full decentralization seem to be a promising approach for
the delivery of HIV care. We showed that when patients start
ART in HCs in rural Lesotho, retention in care is at least as
favourable as in hospitals, both in the short term and in the
long term.
In our study, patients at HCs started ART at an earlier
clinical and immunological stage than those in hospitals.
This difference was consistent across gender and catch-
ment areas. Previous studies from resource-limited settings
50%
100%
A)
B)
60%
70%
80%
90%
50%
100%
60%
70%
80%
90%
1086 676 391 183
1309 841 457 86
Number at risk
Health Centers
Hospitals
Number at risk
Health Centers
Hospitals
0 1 2 3
Health Centers Hospitals
619 335 192 62
733 444 222 42
0 1 2 3
Figure 2. Retention in care over three years, stratified by type of facility (A: female; B: male).
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[17,18,31,33] as well as industrialized countries [34] have
reported similar findings. This may be explained by the
tendency of patients who feel sick to primarily seek care at
a hospital, or because severely ill patients are referred to
hospitals. As a consequence, most patients with severe
opportunistic diseases initiate ART while still hospitalized.
Facilitating access to ART is one of the major reasons for
advocating decentralization of ART delivery. Several studies
described significantly lower travel costs for patients on ART
at HCs as compared to hospitals [15,35]. Thus, patients who
are seen at HCs might have less advanced stages of disease
because of easier access to HIV care at the HC level. Overall,
decentralization of ART delivery seems to be associated
with earlier presentation to HIV care, which might give many
patients the opportunity to start ART earlier in the course of
the disease. As an increasing number of patients will have
an indication to start ART in the next few years [36],
decentralization of care will play a central role in the scale-
up of ART. Starting ART at a very early stage of disease is
endorsed by a recent study from Uganda reporting good
retention and very low mortality among patients starting ART
at a CD4 cell count 350 cells/ml [37].
Overall crude retention in care was higher in patients
who started ART at HCs. However, after disaggregation by
gender, only men had a significantly higher retention at
HCs compared to hospitals, whereas in women there was
a tendency towards lower retention at HCs. Several studies
from cohorts in rural sub-Saharan Africa have described
poorer short- and long-term outcomes among male patients
[3841]. To our knowledge, the published studies comparing
long-term retention in care between HCs and hospitals
did not show data disaggregated by gender. In our study,
the higher retention among men treated at HCs is mainly
determined by significantly lower rates of LTFU among
men at HCs compared to hospitals. Although these findings
are difficult to explain, our main hypothesis is that this
may be employment related. It is plausible that in rural
Lesotho, where most men work either as subsistence farmers
or as labourers in the construction or mining industries in
neighbouring South Africa, the easier accessibility of HCs may
be of particular benefit to men. This is in line with the recent
finding that in Lesotho, migrant workers are particularly
at risk to be LTFU [42].
A strength of our study is that it was able to compare
retention in care between hospitals and HCs in two different
areas in rural southern Africa. In Lesotho, patients not only
are followed but also have been started on ART at nurse-led
HCs since 2007, which enabled us to report on relatively
long-term clinical outcomes. To our knowledge, this is the
first study reporting on outcomes in HCs and hospitals that is
stratified by gender. In addition, the SolidarMed database
records all movements of patients within the programme
and keeps track of transfers out, limiting the overestimation
of true losses to FUP.
This study has several limitations. Firstly, it is an obser-
vational analysis in which patients were not randomly
assigned to initiating ART at either an HC or a hospital.
Thus, we compared two cohorts with differences in baseline
characteristics, and potential residual confounding might
have affected our results. Secondly, our multivariable models
did not include baseline haemoglobin level as the majority of
individuals did not have a documented haemoglobin value at
baseline. Baseline haemoglobin has been shown to be an
independent predictor of early mortality in patients living
with HIV who are starting ART [43]. Thirdly, we have no
information on possible ‘‘self-transfers’’ who may have left
one facility without a transfer letter and continued ART
elsewhere. Namusobya and colleagues report from Uganda
that silent transfers lead to a considerable overestimation of
LTFU [37]. However, these findings may not be applicable to
our study. A tracing survey conducted in 2011 in Seboche has
shown that of 175 patients LTFU who were traced, only 13
(7%) had changed clinics. The majority of those LTFU were
dead (33%) or had migrated to South Africa (26%) [44].
Finally, we did not have any information on the causes of
death, ascertainment of death was limited and we could
not rely on the systematic tracing of patients LTFU at all sites.
It is known that standard mortality estimates underesti-
mate true programme mortality as patients LTFU are at
increased risk of death [45,46]. The data from the survey on
those LTFU in Seboche indicate that one-third of those
LTFU may be dead [44]. However, no data from a syste-
matic tracing survey are available from Paray. In this area,
mortality may be particularly underestimated, as the pre-
viously described socio-economic and geographical condi-
tions have a negative impact on the tracing of these patients
and ascertainment of outcomes is rare.
It is not clear whether the findings of our study may apply
to other settings in Africa. The setting of our study is fairly
unique due to the small districts and particular geographic
conditions of Lesotho compared to other African countries.
Moreover, the support of SolidarMed likely increased the
quality of care at HCs. HCs may perform less well in settings
without any support from NGOs or other implementing
partners. More studies from different settings comparing
full decentralization of ART to hospital-based ART are needed
to examine the external validity of our findings.
Conclusions
Task shifting and decentralization have become common
practices in rural, resource-limited settings to scale up the
provision of ART. Our study provides important data from
Table 3. Health centres versus hospitals: adjusted outcomes
by gender (hospitals are the reference)
Overall Male Female
Retention 1.10 (0.941.28) 1.53 (1.201.96) 0.89 (0.731.09)
No follow-up 0.62 (0.390.98) 0.67 (0.311.43) 0.60 (0.341.07)
Mortality 0.98 (0.801.19) 0.79 (0.591.06) 1.19 (0.911.57)
LTFU 0.98 (0.821.18) 0.68 (0.510.93) 1.21 (0.951.51)
The estimates are ORs for retention and no FUP, and sub-distribution
hazard ratios from competing risk regression for mortality and
LTFU. Analyses are adjusted for age, baseline CD4 cell count, clinical
WHO stage, type of NNRTI and catchment area. LTFU: Lost to
follow-up.
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Lesotho, a country with a particularly high HIV prevalence
and one of the pioneers in task shifting of HIV care. This
information is valuable considering the few large-scale direct
comparisons of different strategies for ART delivery per-
formed outside of South Africa. Our study indicates that rural
nurse-led HCs perform at least as well as their parent
hospitals: HCs had fewer early losses, and long-term reten-
tion in care was comparable to that in hospitals. Starting and
following ART at the HCs appear to be beneficial for men:
those treated at HCs had a higher three-year retention
compared to men in hospitals, mainly because they were less
likely to be LTFU in these facilities. Although this may be
explained partly by the lower proportion of patients with
advanced clinical disease in HCs, other reasons such as a
lower number of patients per caregiver, the proximity of the
treatment facility and lower transport costs might play
important roles.
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